Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125321211 | 12532121 | 1 | I | 20160627 | 20160706 | 20160706 | EXP | PHHY2016BR091563 | NOVARTIS | 0.00 | M | Y | 100.00000 | KG | 20160706 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125321211 | 12532121 | 1 | PS | FORASEQ | BUDESONIDEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 400 UG, UNK | U | 20831 | 400 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 2 | SS | FORASEQ | BUDESONIDEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 400 UG, UNK | U | 20831 | 400 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 3 | SS | FORASEQ | BUDESONIDEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 400 UG, UNK | U | 20831 | 400 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 4 | SS | FORASEQ | BUDESONIDEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 400 UG, UNK | U | 20831 | 400 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 5 | SS | FORASEQ | BUDESONIDEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 400 UG, UNK | U | 20831 | 400 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 6 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF(HYDROCHLOROTHIAZIDE 12.5 MG, VALSARTAN 80 MG), UNK | U | 0 | 1 | DF | TABLET | ||||||
| 125321211 | 12532121 | 7 | SS | MIFLONIDE | BUDESONIDE | 1 | Respiratory (inhalation) | 200 UG, UNK | U | 0 | 200 | UG | CAPSULE | ||||||
| 125321211 | 12532121 | 8 | SS | FORADIL | FORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 60 MG, UNK | U | 20831 | 60 | MG | CAPSULE | ||||||
| 125321211 | 12532121 | 9 | SS | OPTI-FREE (PANCRELIPASETYROSINE) | PANCRELIPASETYROSINE | 1 | Ophthalmic | U | 0 | SOLUTION | |||||||||
| 125321211 | 12532121 | 10 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125321211 | 12532121 | 1 | Product used for unknown indication |
| 125321211 | 12532121 | 6 | Product used for unknown indication |
| 125321211 | 12532121 | 7 | Product used for unknown indication |
| 125321211 | 12532121 | 8 | Product used for unknown indication |
| 125321211 | 12532121 | 9 | Product used for unknown indication |
| 125321211 | 12532121 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125321211 | 12532121 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125321211 | 12532121 | Bronchitis | |
| 125321211 | 12532121 | Emphysema | |
| 125321211 | 12532121 | Fall | |
| 125321211 | 12532121 | Hypoacusis | |
| 125321211 | 12532121 | Mobility decreased | |
| 125321211 | 12532121 | Peripheral venous disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125321211 | 12532121 | 1 | 20160109 | 0 | ||
| 125321211 | 12532121 | 2 | 20160210 | 0 | ||
| 125321211 | 12532121 | 3 | 20160404 | 0 | ||
| 125321211 | 12532121 | 4 | 20160511 | 0 | ||
| 125321211 | 12532121 | 5 | 20160610 | 0 |